StratGraph
Companies / Financials
NDAQ

Nasdaq, Inc.

Financial Exchanges & Data

Financial Exchanges & DataAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health74
Growth61
Profitability86
Cash generationn/a
Balance sheetn/a
Dilution control75
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)20.9%Revenue growth (FY)11.6%Revenue CAGR (3y)9.9%Gross margin63.5%Operating margin28.2%Net margin21.6%Free cash flow margin24.1%R&D / revenue—Stock comp / revenue2.0%Net debt / operating cash flow3.92xCurrent ratio1.01Diluted share count change-0.1%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$5.9B$6.2B$6.1B$7.4B$8.3B
Gross profit$3.4B$3.6B$3.9B$4.6B$5.2B
Operating income$1.4B$1.6B$1.6B$1.8B$2.3B
Net income$1.2B$1.1B$1.1B$1.1B$1.8B
Operating cash flow$1.1B$1.7B$1.7B$1.9B$2.3B
Capital expenditure$163M$152M$158M$207M$266M
Free cash flow$920M$1.6B$1.5B$1.7B$2.0B
Stock-based comp$90M$106M$122M$141M$165M
Buybacks$468M$308M$269M$145M$616M
Dividends$350M$383M$441M$541M$601M
Cash$393M$502M$453M$592M$604M
Total debt$6.8B$6.1B$10.7B$9.9B$9.4B
Equity$6.4B$6.2B$10.8B$11.2B$12.2B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.